Next Article in Journal
Prognostic Gene Signature for Squamous Cell Carcinoma with a Higher Risk for Treatment Failure and Accelerated MEK-ERK Pathway Activity
Previous Article in Journal
PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System
Previous Article in Special Issue
Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma
 
 
Review

Article Versions Notes

Cancers 2021, 13(20), 5181; https://doi.org/10.3390/cancers13205181
Action Date Notes Link
article pdf uploaded. 15 October 2021 16:28 CEST Version of Record https://www.mdpi.com/2072-6694/13/20/5181/pdf-vor
article xml file uploaded 18 October 2021 06:21 CEST Original file -
article xml uploaded. 18 October 2021 06:21 CEST Update -
article pdf uploaded. 18 October 2021 06:21 CEST Updated version of record https://www.mdpi.com/2072-6694/13/20/5181/pdf-vor
article html file updated 18 October 2021 06:23 CEST Original file -
article xml file uploaded 18 October 2021 08:44 CEST Update -
article xml uploaded. 18 October 2021 08:44 CEST Update -
article pdf uploaded. 18 October 2021 08:45 CEST Updated version of record https://www.mdpi.com/2072-6694/13/20/5181/pdf-vor
article html file updated 18 October 2021 08:46 CEST Update -
article xml file uploaded 18 October 2021 08:49 CEST Update -
article xml uploaded. 18 October 2021 08:49 CEST Update https://www.mdpi.com/2072-6694/13/20/5181/xml
article pdf uploaded. 18 October 2021 08:49 CEST Updated version of record https://www.mdpi.com/2072-6694/13/20/5181/pdf
article html file updated 18 October 2021 08:51 CEST Update -
article html file updated 30 July 2022 11:14 CEST Update https://www.mdpi.com/2072-6694/13/20/5181/html
Back to TopTop